Progyny (PGNY) Operating Expenses (2018 - 2026)

Progyny (PGNY) has 9 years of Operating Expenses data on file, last reported at $47.7 million in Q1 2026.

• Quarterly Operating Expenses fell 7.62% year-over-year to $47.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215.3 million (up 11.17% YoY) and the FY2025 annual result came in at $219.2 million, up 17.91% from the prior year.
• Operating Expenses declined to $47.7 million in Q1 2026 per PGNY's latest filing, from $61.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $61.7 million in Q4 2025 and bottomed at $33.0 million in Q1 2022.
• The 5-year median for Operating Expenses is $45.5 million (2023), against an average of $45.5 million.
• The widest annual swing landed in 2022, when Operating Expenses jumped 95.1%; it then slipped 7.62% in 2026.
• Tracing PGNY's Operating Expenses over 5 years: stood at $41.2 million in 2022, then increased by 4.63% to $43.1 million in 2023, then advanced by 10.56% to $47.6 million in 2024, then increased by 29.41% to $61.7 million in 2025, then fell by 22.65% to $47.7 million in 2026.
• Per Business Quant, the three latest PGNY Operating Expenses figures stand at $47.7 million (Q1 2026), $61.7 million (Q4 2025), and $51.3 million (Q3 2025).

Peer Comparison